0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Global and China Neuroprotection Market Size, Status and Forecast 2020-2026
Published Date: September 2020
|
Report Code: QYRE-Auto-7P3511
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global and China Neuroprotection Market Size Status and Forecast 2020 2026

Global and China Neuroprotection Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-7P3511
Report
September 2020
95 Pages
QYResearch
Region: Global, United States, Southeast Asia, North America, Europe, France, Canada, Germany, South Korea, Russia, Italy, Turkey, Saudi Arabia, UAE,
Description
Table of Content
Tables & Figures
Global Neuroprotection Scope and Market Size
Neuroprotection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuroprotection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
    Free Anti-Inflammatory Agents
    Radical Trapping Agents (Antioxidants)
    Apoptosis Inhibitors
    Glutamate Antagonists (Anti-Excitotoxic Agents)
    Neurotrophic Factors (NTFs)
    Stimulants
    Metal Ion Chelators
    Other Products
Market segment by Application, split into
    Prevention
    Treatment
Based on regional and country-level analysis, the Neuroprotection market has been segmented as follows:
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Latin America
        Mexico
        Brazil
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Neuroprotection market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
    F. Hoffmann-La Roche
    Eli Lilly and Company
    Daiichi Sankyo Company
    Allergan
    Novartis
    AstraZeneca
    Dr. Reddy's Laboratories
    Astrocyte Pharmaceuticals
    Teva Pharmaceutical Industries
    Biogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroprotection Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Free Anti-Inflammatory Agents
1.2.3 Radical Trapping Agents (Antioxidants)
1.2.4 Apoptosis Inhibitors
1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.6 Neurotrophic Factors (NTFs)
1.2.7 Stimulants
1.2.8 Metal Ion Chelators
1.2.9 Other Products
1.3 Market by Application
1.3.1 Global Neuroprotection Market Share by Application: 2020 VS 2026
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroprotection Market Perspective (2015-2026)
2.2 Global Neuroprotection Growth Trends by Regions
2.2.1 Neuroprotection Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuroprotection Historic Market Share by Regions (2015-2020)
2.2.3 Neuroprotection Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroprotection Players by Market Size
3.1.1 Global Top Neuroprotection Players by Revenue (2015-2020)
3.1.2 Global Neuroprotection Revenue Market Share by Players (2015-2020)
3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroprotection Revenue
3.4 Global Neuroprotection Market Concentration Ratio
3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2019
3.5 Key Players Neuroprotection Area Served
3.6 Key Players Neuroprotection Product Solution and Service
3.7 Date of Enter into Neuroprotection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroprotection Breakdown Data by Type (2015-2026)
4.1 Global Neuroprotection Historic Market Size by Type (2015-2020)
4.2 Global Neuroprotection Forecasted Market Size by Type (2021-2026)
5 Neuroprotection Breakdown Data by Application (2015-2026)
5.1 Global Neuroprotection Historic Market Size by Application (2015-2020)
5.2 Global Neuroprotection Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuroprotection Market Size (2015-2026)
6.2 North America Neuroprotection Market Size by Type (2015-2020)
6.3 North America Neuroprotection Market Size by Application (2015-2020)
6.4 North America Neuroprotection Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Neuroprotection Market Size (2015-2026)
7.2 Europe Neuroprotection Market Size by Type (2015-2020)
7.3 Europe Neuroprotection Market Size by Application (2015-2020)
7.4 Europe Neuroprotection Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Neuroprotection Market Size (2015-2026)
8.2 China Neuroprotection Market Size by Type (2015-2020)
8.3 China Neuroprotection Market Size by Application (2015-2020)
8.4 China Neuroprotection Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Neuroprotection Market Size (2015-2026)
9.2 Japan Neuroprotection Market Size by Type (2015-2020)
9.3 Japan Neuroprotection Market Size by Application (2015-2020)
9.4 Japan Neuroprotection Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Neuroprotection Market Size (2015-2026)
10.2 Southeast Asia Neuroprotection Market Size by Type (2015-2020)
10.3 Southeast Asia Neuroprotection Market Size by Application (2015-2020)
10.4 Southeast Asia Neuroprotection Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2015-2020))
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Neuroprotection Introduction
11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2015-2020)
11.2.5 Eli Lilly and Company Recent Development
11.3 Daiichi Sankyo Company
11.3.1 Daiichi Sankyo Company Company Details
11.3.2 Daiichi Sankyo Company Business Overview
11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2015-2020)
11.3.5 Daiichi Sankyo Company Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Neuroprotection Introduction
11.4.4 Allergan Revenue in Neuroprotection Business (2015-2020)
11.4.5 Allergan Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neuroprotection Introduction
11.5.4 Novartis Revenue in Neuroprotection Business (2015-2020)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Neuroprotection Introduction
11.6.4 AstraZeneca Revenue in Neuroprotection Business (2015-2020)
11.6.5 AstraZeneca Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2015-2020)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 Astrocyte Pharmaceuticals
11.8.1 Astrocyte Pharmaceuticals Company Details
11.8.2 Astrocyte Pharmaceuticals Business Overview
11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2015-2020)
11.8.5 Astrocyte Pharmaceuticals Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2015-2020)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Neuroprotection Introduction
11.10.4 Biogen Revenue in Neuroprotection Business (2015-2020)
11.10.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 3. Key Players of Free Anti-Inflammatory Agents
    Table 4. Key Players of Radical Trapping Agents (Antioxidants)
    Table 5. Key Players of Apoptosis Inhibitors
    Table 6. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
    Table 7. Key Players of Neurotrophic Factors (NTFs)
    Table 8. Key Players of Stimulants
    Table 9. Key Players of Metal Ion Chelators
    Table 10. Key Players of Other Products
    Table 11. Global Neuroprotection Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 12. Global Neuroprotection Market Size by Regions (US$ Million): 2020 VS 2026
    Table 13. Global Neuroprotection Market Size by Regions (2015-2020) (US$ Million)
    Table 14. Global Neuroprotection Market Share by Regions (2015-2020)
    Table 15. Global Neuroprotection Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 16. Global Neuroprotection Market Share by Regions (2021-2026)
    Table 17. Neuroprotection Market Market Trends
    Table 18. Neuroprotection Market Drivers
    Table 19. Neuroprotection Market Challenges
    Table 20. Neuroprotection Market Restraints
    Table 21. Global Neuroprotection Revenue by Players (2015-2020) (US$ Million)
    Table 22. Global Neuroprotection Market Share by Players (2015-2020)
    Table 23. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2019)
    Table 24. Global Neuroprotection by Players Market Concentration Ratio (CR5 and HHI)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Neuroprotection Product Solution and Service
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 29. Global Neuroprotection Market Size Share by Type (2015-2020)
    Table 30. Global Neuroprotection Revenue Market Share by Type (2021-2026)
    Table 31. Global Neuroprotection Market Size Share by Application (2015-2020)
    Table 32. Global Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 33. Global Neuroprotection Market Size Share by Application (2021-2026)
    Table 34. North America Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 35. North America Neuroprotection Market Share by Type (2015-2020)
    Table 36. North America Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 37. North America Neuroprotection Market Share by Application (2015-2020)
    Table 38. North America Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 39. North America Neuroprotection Market Share by Country (2015-2020)
    Table 40. Europe Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 41. Europe Neuroprotection Market Share by Type (2015-2020)
    Table 42. Europe Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 43. Europe Neuroprotection Market Share by Application (2015-2020)
    Table 44. Europe Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 45. Europe Neuroprotection Market Share by Country (2015-2020)
    Table 46. China Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 47. China Neuroprotection Market Share by Type (2015-2020)
    Table 48. China Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 49. China Neuroprotection Market Share by Application (2015-2020)
    Table 50. China Neuroprotection Market Size by Region (US$ Million) (2015-2020)
    Table 51. China Neuroprotection Market Share by Region (2015-2020)
    Table 52. Japan Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 53. Japan Neuroprotection Market Share by Type (2015-2020)
    Table 54. Japan Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 55. Japan Neuroprotection Market Share by Application (2015-2020)
    Table 56. Japan Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 57. Japan Neuroprotection Market Share by Country (2015-2020)
    Table 58. Southeast Asia Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 59. Southeast Asia Neuroprotection Market Share by Type (2015-2020)
    Table 60. Southeast Asia Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 61. Southeast Asia Neuroprotection Market Share by Application (2015-2020)
    Table 62. Southeast Asia Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 63. Southeast Asia Neuroprotection Market Share by Country (2015-2020)
    Table 64. F. Hoffmann-La Roche Company Details
    Table 65. F. Hoffmann-La Roche Business Overview
    Table 66. F. Hoffmann-La Roche Product
    Table 67. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 68. F. Hoffmann-La Roche Recent Development
    Table 69. Eli Lilly and Company Company Details
    Table 70. Eli Lilly and Company Business Overview
    Table 71. Eli Lilly and Company Product
    Table 72. Eli Lilly and Company Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 73. Eli Lilly and Company Recent Development
    Table 74. Daiichi Sankyo Company Company Details
    Table 75. Daiichi Sankyo Company Business Overview
    Table 76. Daiichi Sankyo Company Product
    Table 77. Daiichi Sankyo Company Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 78. Daiichi Sankyo Company Recent Development
    Table 79. Allergan Company Details
    Table 80. Allergan Business Overview
    Table 81. Allergan Product
    Table 82. Allergan Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 83. Allergan Recent Development
    Table 84. Novartis Company Details
    Table 85. Novartis Business Overview
    Table 86. Novartis Product
    Table 87. Novartis Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 88. Novartis Recent Development
    Table 89. AstraZeneca Company Details
    Table 90. AstraZeneca Business Overview
    Table 91. AstraZeneca Product
    Table 92. AstraZeneca Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 93. AstraZeneca Recent Development
    Table 94. Dr. Reddy's Laboratories Company Details
    Table 95. Dr. Reddy's Laboratories Business Overview
    Table 96. Dr. Reddy's Laboratories Product
    Table 97. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 98. Dr. Reddy's Laboratories Recent Development
    Table 99. Astrocyte Pharmaceuticals Business Overview
    Table 100. Astrocyte Pharmaceuticals Product
    Table 101. Astrocyte Pharmaceuticals Company Details
    Table 102. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 103. Astrocyte Pharmaceuticals Recent Development
    Table 104. Teva Pharmaceutical Industries Company Details
    Table 105. Teva Pharmaceutical Industries Business Overview
    Table 106. Teva Pharmaceutical Industries Product
    Table 107. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 108. Teva Pharmaceutical Industries Recent Development
    Table 109. Biogen Company Details
    Table 110. Biogen Business Overview
    Table 111. Biogen Product
    Table 112. Biogen Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 113. Biogen Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuroprotection Market Share by Type: 2020 VS 2026
    Figure 2. Free Anti-Inflammatory Agents Features
    Figure 3. Radical Trapping Agents (Antioxidants) Features
    Figure 4. Apoptosis Inhibitors Features
    Figure 5. Glutamate Antagonists (Anti-Excitotoxic Agents) Features
    Figure 6. Neurotrophic Factors (NTFs) Features
    Figure 7. Stimulants Features
    Figure 8. Metal Ion Chelators Features
    Figure 9. Other Products Features
    Figure 10. Global Neuroprotection Market Share by Application: 2020 VS 2026
    Figure 11. Prevention Case Studies
    Figure 12. Treatment Case Studies
    Figure 13. Neuroprotection Report Years Considered
    Figure 14. Global Neuroprotection Market Size (US$ Million), YoY Growth 2015-2026
    Figure 15. Global Neuroprotection Market Share by Regions: 2020 VS 2026
    Figure 16. Global Neuroprotection Market Share by Regions (2021-2026)
    Figure 17. Global Neuroprotection Market Share by Players in 2019
    Figure 18. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2019
    Figure 19. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2019
    Figure 20. North America Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 21. United States Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 22. Canada Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 23. Europe Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 24. Germany Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 25. France Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 26. U.K. Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 27. Italy Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 28. Russia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 29. Nordic Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 30. Rest of Europe Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 31. Asia-Pacific Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 32. China Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 33. Japan Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 34. South Korea Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 35. Southeast Asia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 36. India Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 37. Australia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 38. Rest of Asia-Pacific Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 39. Latin America Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 40. Mexico Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 41. Brazil Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 42. Middle East & Africa Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 43. Turkey Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 44. Saudi Arabia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 45. UAE Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 46. Rest of Middle East & Africa Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 48. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 49. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 50. Allergan Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 51. Novartis Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 52. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 54. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 56. Biogen Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Global Neuroprotection Scope and Market Size
Neuroprotection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuroprotection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
    Free Anti-Inflammatory Agents
    Radical Trapping Agents (Antioxidants)
    Apoptosis Inhibitors
    Glutamate Antagonists (Anti-Excitotoxic Agents)
    Neurotrophic Factors (NTFs)
    Stimulants
    Metal Ion Chelators
    Other Products
Market segment by Application, split into
    Prevention
    Treatment
Based on regional and country-level analysis, the Neuroprotection market has been segmented as follows:
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Latin America
        Mexico
        Brazil
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Neuroprotection market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
    F. Hoffmann-La Roche
    Eli Lilly and Company
    Daiichi Sankyo Company
    Allergan
    Novartis
    AstraZeneca
    Dr. Reddy's Laboratories
    Astrocyte Pharmaceuticals
    Teva Pharmaceutical Industries
    Biogen
Read More
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroprotection Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Free Anti-Inflammatory Agents
1.2.3 Radical Trapping Agents (Antioxidants)
1.2.4 Apoptosis Inhibitors
1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.6 Neurotrophic Factors (NTFs)
1.2.7 Stimulants
1.2.8 Metal Ion Chelators
1.2.9 Other Products
1.3 Market by Application
1.3.1 Global Neuroprotection Market Share by Application: 2020 VS 2026
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuroprotection Market Perspective (2015-2026)
2.2 Global Neuroprotection Growth Trends by Regions
2.2.1 Neuroprotection Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuroprotection Historic Market Share by Regions (2015-2020)
2.2.3 Neuroprotection Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroprotection Players by Market Size
3.1.1 Global Top Neuroprotection Players by Revenue (2015-2020)
3.1.2 Global Neuroprotection Revenue Market Share by Players (2015-2020)
3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuroprotection Revenue
3.4 Global Neuroprotection Market Concentration Ratio
3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2019
3.5 Key Players Neuroprotection Area Served
3.6 Key Players Neuroprotection Product Solution and Service
3.7 Date of Enter into Neuroprotection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroprotection Breakdown Data by Type (2015-2026)
4.1 Global Neuroprotection Historic Market Size by Type (2015-2020)
4.2 Global Neuroprotection Forecasted Market Size by Type (2021-2026)
5 Neuroprotection Breakdown Data by Application (2015-2026)
5.1 Global Neuroprotection Historic Market Size by Application (2015-2020)
5.2 Global Neuroprotection Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuroprotection Market Size (2015-2026)
6.2 North America Neuroprotection Market Size by Type (2015-2020)
6.3 North America Neuroprotection Market Size by Application (2015-2020)
6.4 North America Neuroprotection Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Neuroprotection Market Size (2015-2026)
7.2 Europe Neuroprotection Market Size by Type (2015-2020)
7.3 Europe Neuroprotection Market Size by Application (2015-2020)
7.4 Europe Neuroprotection Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Neuroprotection Market Size (2015-2026)
8.2 China Neuroprotection Market Size by Type (2015-2020)
8.3 China Neuroprotection Market Size by Application (2015-2020)
8.4 China Neuroprotection Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Neuroprotection Market Size (2015-2026)
9.2 Japan Neuroprotection Market Size by Type (2015-2020)
9.3 Japan Neuroprotection Market Size by Application (2015-2020)
9.4 Japan Neuroprotection Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Neuroprotection Market Size (2015-2026)
10.2 Southeast Asia Neuroprotection Market Size by Type (2015-2020)
10.3 Southeast Asia Neuroprotection Market Size by Application (2015-2020)
10.4 Southeast Asia Neuroprotection Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2015-2020))
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Neuroprotection Introduction
11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2015-2020)
11.2.5 Eli Lilly and Company Recent Development
11.3 Daiichi Sankyo Company
11.3.1 Daiichi Sankyo Company Company Details
11.3.2 Daiichi Sankyo Company Business Overview
11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2015-2020)
11.3.5 Daiichi Sankyo Company Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Neuroprotection Introduction
11.4.4 Allergan Revenue in Neuroprotection Business (2015-2020)
11.4.5 Allergan Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neuroprotection Introduction
11.5.4 Novartis Revenue in Neuroprotection Business (2015-2020)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Neuroprotection Introduction
11.6.4 AstraZeneca Revenue in Neuroprotection Business (2015-2020)
11.6.5 AstraZeneca Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2015-2020)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 Astrocyte Pharmaceuticals
11.8.1 Astrocyte Pharmaceuticals Company Details
11.8.2 Astrocyte Pharmaceuticals Business Overview
11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2015-2020)
11.8.5 Astrocyte Pharmaceuticals Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2015-2020)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Neuroprotection Introduction
11.10.4 Biogen Revenue in Neuroprotection Business (2015-2020)
11.10.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Read More
List of Tables
    Table 1. Global Neuroprotection Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 3. Key Players of Free Anti-Inflammatory Agents
    Table 4. Key Players of Radical Trapping Agents (Antioxidants)
    Table 5. Key Players of Apoptosis Inhibitors
    Table 6. Key Players of Glutamate Antagonists (Anti-Excitotoxic Agents)
    Table 7. Key Players of Neurotrophic Factors (NTFs)
    Table 8. Key Players of Stimulants
    Table 9. Key Players of Metal Ion Chelators
    Table 10. Key Players of Other Products
    Table 11. Global Neuroprotection Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 12. Global Neuroprotection Market Size by Regions (US$ Million): 2020 VS 2026
    Table 13. Global Neuroprotection Market Size by Regions (2015-2020) (US$ Million)
    Table 14. Global Neuroprotection Market Share by Regions (2015-2020)
    Table 15. Global Neuroprotection Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 16. Global Neuroprotection Market Share by Regions (2021-2026)
    Table 17. Neuroprotection Market Market Trends
    Table 18. Neuroprotection Market Drivers
    Table 19. Neuroprotection Market Challenges
    Table 20. Neuroprotection Market Restraints
    Table 21. Global Neuroprotection Revenue by Players (2015-2020) (US$ Million)
    Table 22. Global Neuroprotection Market Share by Players (2015-2020)
    Table 23. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2019)
    Table 24. Global Neuroprotection by Players Market Concentration Ratio (CR5 and HHI)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Neuroprotection Product Solution and Service
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 29. Global Neuroprotection Market Size Share by Type (2015-2020)
    Table 30. Global Neuroprotection Revenue Market Share by Type (2021-2026)
    Table 31. Global Neuroprotection Market Size Share by Application (2015-2020)
    Table 32. Global Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 33. Global Neuroprotection Market Size Share by Application (2021-2026)
    Table 34. North America Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 35. North America Neuroprotection Market Share by Type (2015-2020)
    Table 36. North America Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 37. North America Neuroprotection Market Share by Application (2015-2020)
    Table 38. North America Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 39. North America Neuroprotection Market Share by Country (2015-2020)
    Table 40. Europe Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 41. Europe Neuroprotection Market Share by Type (2015-2020)
    Table 42. Europe Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 43. Europe Neuroprotection Market Share by Application (2015-2020)
    Table 44. Europe Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 45. Europe Neuroprotection Market Share by Country (2015-2020)
    Table 46. China Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 47. China Neuroprotection Market Share by Type (2015-2020)
    Table 48. China Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 49. China Neuroprotection Market Share by Application (2015-2020)
    Table 50. China Neuroprotection Market Size by Region (US$ Million) (2015-2020)
    Table 51. China Neuroprotection Market Share by Region (2015-2020)
    Table 52. Japan Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 53. Japan Neuroprotection Market Share by Type (2015-2020)
    Table 54. Japan Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 55. Japan Neuroprotection Market Share by Application (2015-2020)
    Table 56. Japan Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 57. Japan Neuroprotection Market Share by Country (2015-2020)
    Table 58. Southeast Asia Neuroprotection Market Size by Type (2015-2020) (US$ Million)
    Table 59. Southeast Asia Neuroprotection Market Share by Type (2015-2020)
    Table 60. Southeast Asia Neuroprotection Market Size by Application (2015-2020) (US$ Million)
    Table 61. Southeast Asia Neuroprotection Market Share by Application (2015-2020)
    Table 62. Southeast Asia Neuroprotection Market Size by Country (US$ Million) (2015-2020)
    Table 63. Southeast Asia Neuroprotection Market Share by Country (2015-2020)
    Table 64. F. Hoffmann-La Roche Company Details
    Table 65. F. Hoffmann-La Roche Business Overview
    Table 66. F. Hoffmann-La Roche Product
    Table 67. F. Hoffmann-La Roche Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 68. F. Hoffmann-La Roche Recent Development
    Table 69. Eli Lilly and Company Company Details
    Table 70. Eli Lilly and Company Business Overview
    Table 71. Eli Lilly and Company Product
    Table 72. Eli Lilly and Company Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 73. Eli Lilly and Company Recent Development
    Table 74. Daiichi Sankyo Company Company Details
    Table 75. Daiichi Sankyo Company Business Overview
    Table 76. Daiichi Sankyo Company Product
    Table 77. Daiichi Sankyo Company Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 78. Daiichi Sankyo Company Recent Development
    Table 79. Allergan Company Details
    Table 80. Allergan Business Overview
    Table 81. Allergan Product
    Table 82. Allergan Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 83. Allergan Recent Development
    Table 84. Novartis Company Details
    Table 85. Novartis Business Overview
    Table 86. Novartis Product
    Table 87. Novartis Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 88. Novartis Recent Development
    Table 89. AstraZeneca Company Details
    Table 90. AstraZeneca Business Overview
    Table 91. AstraZeneca Product
    Table 92. AstraZeneca Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 93. AstraZeneca Recent Development
    Table 94. Dr. Reddy's Laboratories Company Details
    Table 95. Dr. Reddy's Laboratories Business Overview
    Table 96. Dr. Reddy's Laboratories Product
    Table 97. Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 98. Dr. Reddy's Laboratories Recent Development
    Table 99. Astrocyte Pharmaceuticals Business Overview
    Table 100. Astrocyte Pharmaceuticals Product
    Table 101. Astrocyte Pharmaceuticals Company Details
    Table 102. Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 103. Astrocyte Pharmaceuticals Recent Development
    Table 104. Teva Pharmaceutical Industries Company Details
    Table 105. Teva Pharmaceutical Industries Business Overview
    Table 106. Teva Pharmaceutical Industries Product
    Table 107. Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 108. Teva Pharmaceutical Industries Recent Development
    Table 109. Biogen Company Details
    Table 110. Biogen Business Overview
    Table 111. Biogen Product
    Table 112. Biogen Revenue in Neuroprotection Business (2015-2020) (US$ Million)
    Table 113. Biogen Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuroprotection Market Share by Type: 2020 VS 2026
    Figure 2. Free Anti-Inflammatory Agents Features
    Figure 3. Radical Trapping Agents (Antioxidants) Features
    Figure 4. Apoptosis Inhibitors Features
    Figure 5. Glutamate Antagonists (Anti-Excitotoxic Agents) Features
    Figure 6. Neurotrophic Factors (NTFs) Features
    Figure 7. Stimulants Features
    Figure 8. Metal Ion Chelators Features
    Figure 9. Other Products Features
    Figure 10. Global Neuroprotection Market Share by Application: 2020 VS 2026
    Figure 11. Prevention Case Studies
    Figure 12. Treatment Case Studies
    Figure 13. Neuroprotection Report Years Considered
    Figure 14. Global Neuroprotection Market Size (US$ Million), YoY Growth 2015-2026
    Figure 15. Global Neuroprotection Market Share by Regions: 2020 VS 2026
    Figure 16. Global Neuroprotection Market Share by Regions (2021-2026)
    Figure 17. Global Neuroprotection Market Share by Players in 2019
    Figure 18. Global Top Neuroprotection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotection as of 2019
    Figure 19. The Top 10 and 5 Players Market Share by Neuroprotection Revenue in 2019
    Figure 20. North America Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 21. United States Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 22. Canada Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 23. Europe Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 24. Germany Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 25. France Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 26. U.K. Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 27. Italy Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 28. Russia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 29. Nordic Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 30. Rest of Europe Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 31. Asia-Pacific Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 32. China Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 33. Japan Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 34. South Korea Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 35. Southeast Asia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 36. India Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 37. Australia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 38. Rest of Asia-Pacific Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 39. Latin America Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 40. Mexico Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 41. Brazil Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 42. Middle East & Africa Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 43. Turkey Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 44. Saudi Arabia Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 45. UAE Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 46. Rest of Middle East & Africa Neuroprotection Market Size YoY Growth (2015-2026) & (US$ Million)
    Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 48. Eli Lilly and Company Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 49. Daiichi Sankyo Company Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 50. Allergan Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 51. Novartis Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 52. AstraZeneca Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 54. Astrocyte Pharmaceuticals Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 56. Biogen Revenue Growth Rate in Neuroprotection Business (2015-2020)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Clear Glass Vial Market Research Report 2020
Global Clear Glass Vial Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-17U3509
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Aminoguanidine Bicarbonate Market Research Report 2020
Global Aminoguanidine Bicarbonate Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-37F3227
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Pharmaceutical Amber Glass Bottles Market Research Report 2020
Global Pharmaceutical Amber Glass Bottles Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-22D3270
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

Global Boron Tribromide Market Research Report 2020
Global Boron Tribromide Market Research Report 2020

120 Pages
Type: Report
Code: QYRE-Auto-31N3242
Fri Oct 02 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0